Product image of Metformin Fourrts (Uk) Pharmacare (Metformin Hydrochloride) supplied by GNH India

Metformin Fourrts (Uk) Pharmacare

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metformin Fourrts (Uk) Pharmacare (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metformin Fourrts (Uk) Pharmacare, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus and related insulin‑resistant conditions.

GNH India supplies Metformin Fourrts (Uk) Pharmacare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Fourrts (Uk) Pharmacare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metformin Fourrts (Uk) Pharmacare is indicated for conditions that involve impaired glucose regulation within the antidiabetic therapeutic area.

  • Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose to improve overall glycaemic control.
  • Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes by enhancing insulin sensitivity.
  • Polycystic ovary syndrome (PCOS): helps normalize insulin resistance and may improve menstrual regularity.

How It Works

  • Metformin Hydrochloride reduces hepatic gluconeogenesis, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). These actions collectively lower circulating glucose levels without directly stimulating insulin secretion, making it effective for managing hyperglycaemia in type 2 diabetes.

Side Effects

Metformin Fourrts (Uk) Pharmacare may be associated with a range of adverse reactions.

Common Side Effects

  • Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite.
  • Diarrhoea: frequent loose stools, especially during treatment initiation.
  • Metallic taste: transient alteration in taste perception.
  • Decreased vitamin B12 levels: may develop with long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: a rare but life‑threatening accumulation of lactate.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Hepatotoxicity: marked elevation of liver enzymes or liver failure.
  • Hypoglycaemia: when combined with other glucose‑lowering agents.

Precautions & Warnings

When prescribing Metformin Fourrts (Uk) Pharmacare, clinicians should consider several safety measures.

  • Renal function monitoring: assess creatinine clearance before initiation and periodically thereafter.
  • Hepatic function assessment: evaluate liver enzymes to reduce risk of lactic acidosis.
  • Lactic acidosis risk: avoid use in patients with conditions predisposing to hypoxia or severe infection.
  • Concomitant medication review: identify drugs that may impair renal clearance of metformin.
  • Elderly patients: start at lower doses and monitor tolerance closely.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Metformin Fourrts (Uk) Pharmacare can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Cimetidine: can raise metformin plasma concentrations.
  • Alcohol (excessive): enhances risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycaemic symptoms.
  • ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment.
  • Diuretics: may reduce renal clearance of metformin, necessitating monitoring.

Frequently Asked Questions

Metformin Fourrts (Uk) Pharmacare is a prescription oral medication used to improve blood glucose control in adults with type 2 diabetes mellitus and other insulin‑resistant conditions such as prediabetes and polycystic ovary syndrome.

Metformin Hydrochloride lowers blood sugar by decreasing hepatic glucose production, reducing intestinal glucose absorption, and increasing peripheral insulin sensitivity through activation of the AMP‑activated protein kinase (AMPK) pathway.

The appropriate dose of Metformin Fourrts (Uk) Pharmacare is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy.

Safety of Metformin Fourrts during pregnancy or lactation should be evaluated by a qualified clinician. It may be used when the potential benefit justifies any potential risk, but the decision must be individualized.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy because it improves insulin sensitivity without causing weight gain. Compared with sulfonylureas, it has a lower risk of hypoglycaemia, and unlike insulin, it is administered orally.

Store Metformin Fourrts (Uk) Pharmacare at room temperature, below 25 °C, in the original packaging, and protect it from moisture and direct sunlight to maintain product stability.

Metformin Fourrts is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed.

The most serious risk is lactic acidosis, a rare but potentially fatal condition. Other serious concerns include severe skin reactions such as Stevens‑Johnson syndrome and significant liver injury, especially in patients with renal or hepatic impairment.

Metformin Fourrts should be avoided in patients with severe renal impairment, acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without adequate renal function monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT